Accelerate Diagnostics Share Holder Equity 2010-2024 | AXDXQ
Accelerate Diagnostics share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
Accelerate Diagnostics Annual Share Holder Equity
(Millions of US $) |
| 2024 |
$-56 |
| 2023 |
$-20 |
| 2022 |
$-22 |
| 2021 |
$-35 |
| 2020 |
$-63 |
| 2019 |
$-7 |
| 2018 |
$57 |
| 2017 |
$119 |
| 2016 |
$78 |
| 2015 |
$133 |
| 2014 |
$66 |
| 2013 |
$42 |
| 2012 |
$12 |
| 2012 |
$15 |
| 2011 |
$5 |
| 2010 |
$5 |
| 2009 |
$4 |
Accelerate Diagnostics Quarterly Share Holder Equity
(Millions of US $) |
| 2024-12-31 |
$-56 |
| 2024-09-30 |
$-48 |
| 2024-06-30 |
$-35 |
| 2024-03-31 |
$-26 |
| 2023-12-31 |
$-20 |
| 2023-09-30 |
$-35 |
| 2023-06-30 |
$-39 |
| 2023-03-31 |
$-39 |
| 2022-12-31 |
$-22 |
| 2022-09-30 |
$-10 |
| 2022-06-30 |
$-62 |
| 2022-03-31 |
$-56 |
| 2021-12-31 |
$-35 |
| 2021-09-30 |
$-40 |
| 2021-06-30 |
$-70 |
| 2021-03-31 |
$-66 |
| 2020-12-31 |
$-63 |
| 2020-09-30 |
$-50 |
| 2020-06-30 |
$-37 |
| 2020-03-31 |
$-23 |
| 2019-12-31 |
$-7 |
| 2019-09-30 |
$10 |
| 2019-06-30 |
$26 |
| 2019-03-31 |
$43 |
| 2018-12-31 |
$57 |
| 2018-09-30 |
$77 |
| 2018-06-30 |
$95 |
| 2018-03-31 |
$106 |
| 2017-12-31 |
$119 |
| 2017-09-30 |
$130 |
| 2017-06-30 |
$142 |
| 2017-03-31 |
$69 |
| 2016-12-31 |
$78 |
| 2016-09-30 |
$91 |
| 2016-06-30 |
$105 |
| 2016-03-31 |
$120 |
| 2015-12-31 |
$133 |
| 2015-09-30 |
$40 |
| 2015-06-30 |
$49 |
| 2015-03-31 |
$59 |
| 2014-12-31 |
$66 |
| 2014-09-30 |
$72 |
| 2014-06-30 |
$79 |
| 2014-03-31 |
$39 |
| 2013-12-31 |
$42 |
| 2013-09-30 |
$45 |
| 2013-06-30 |
$28 |
| 2013-03-31 |
$30 |
| 2012-12-31 |
$12 |
| 2012-10-31 |
$13 |
| 2012-09-30 |
|
| 2012-07-31 |
$15 |
| 2012-06-30 |
|
| 2012-04-30 |
$4 |
| 2012-03-31 |
|
| 2012-01-31 |
$4 |
| 2011-10-31 |
$5 |
| 2011-07-31 |
$5 |
| 2011-04-30 |
$5 |
| 2011-01-31 |
$5 |
| 2010-10-31 |
$5 |
| 2010-07-31 |
$5 |
| 2010-04-30 |
$3 |
| 2010-01-31 |
$3 |
| 2009-10-31 |
$3 |
| 2009-07-31 |
$4 |
| 2009-04-30 |
$4 |
| 2009-01-31 |
$4 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED INSTRUMENTS |
$0.001B |
$0.012B |
|
Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado.
|
